Photoproteins: Important new tools in drug discovery

Assay and Drug Development Technologies

Volumn 6, Issue 5, 2008, Pages 659-671

  Eglen, Richard M ^a   Reisine, Terry ^b  

^a PERKINELMER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PHOTOPROTEIN;

BIOSENSOR; CALCIUM CELL LEVEL; CALCIUM SIGNALING; HIGH THROUGHPUT SCREENING; HUMAN; LUMINESCENCE; NONHUMAN; PROTEIN ANALYSIS; REVIEW;

ANIMALS; CALCIUM; CALCIUM SIGNALING; DRUG DESIGN; FLUORESCENT DYES; HUMANS; LUMINESCENT PROTEINS; PHARMACOLOGY; RECEPTORS, G-PROTEIN-COUPLED; RESEARCH;

EID: 57049122346     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2008.160     Document Type: Review

References (88)

1. Eglen RM, Bosse R, Reisine T: Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. Assay Drug Dev Technol 2007;5:425-451.
2. Wilson S, Bergsma D: Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. Drug Des Discov 2000;17:105-114.
3. nd ed. M. Nijhoff, Boston, 1995.
4. Comley J: Changing dynamics in dispense and imaging assays. Drug Discov World 2006;13:35-51.
5. Blake AD, Bot G, Reisine T: Structure-function analysis of the cloned opiate receptors: peptide and small molecule interactions. Chem Biol 1996;3:967-972.
6. Reisine T, Bell GI: Molecular biology of somatostatin receptors. Endocr Rev 1995;16:427-442.
7. i signaling in the heart: the good, the bad, and the ugly. Circ Res 2005;97:507-509.
8. 2+ channels in canine heart failure. Circ Res 2005;97:566-573.
9. 2+: molecular determinants and functional consequences. Physiol Rev 2006;86:369-408.
10. Clapham DE, Neer E: New roles for G protein βγ-dimers in transmembrane signaling. Nature 1993;365:403-406.
11. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-257.
12. Hescheler J, Rosenthal W, Trautwein W, Schultz G: The GTP binding protein, Go, regulates neuronal calcium channels. Nature 1987;325:445-447.
13. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B: Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991;353:43-48.
14. Worley PF, Baraban JM, Van Dop C, Neer EJ, Snyder SH: Go, a guanine nucleotide-binding protein: immunohistochemical localization in rat brain resembles distribution of second messenger systems. Proc Natl Acad Sci U S A 1986;83:4561-4565.
15. Milligan G, Marshall F, Rees S: Galpha16 as a universal G protein adapter: implication for agonist screening strategies. Trends Pharmacol Sci 1996;17:235-237.
16. Offermanns S, Simon MI: G alpha15 and G alpha16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995;270:15175-15180.
17. Conklin BR, Herzmark P, Ishida S, Voyno-Yasenetskaya TA, Sun Y, Farfel Z, et al.: Substitution of three amino acids switches receptor specificity of Gq to that of Gi. Nature 1993;363:274-276.
18. Conklin BR, Herzmark P, Ishida S, Voyno-Yasenetskaya TA, Sun Y, Farfel Z, et al.: Carboxyl-terminal mutations of Gαq and Gαs that alter the fidelity of receptor activation. Mol Pharmacol 1996;50:885-890.
19. Bennett PB, Guthrie HR: Trends in ion channel drug discovery: advances in screening technologies. Trends Biotechnol 2003;21:563-569.
20. Netzer R, Bischoff U, Ebneth A: HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery. Curr Opin Drug Discov Dev 2003;6:462-469.
21. rd, Main MJ: An industrial perspective on utilizing functional ion channel assays for high throughput screening. Receptors Channels 2002;8:269-282.
22. Gramowski A, JÅgelt K, StÅwe S, Schulze R, McGregor GP, Wartenberg-Demand A, et al.: Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips. Eur J Neurosci 2006;24:455-465.
23. Gramowski A, Jugelt K, Weiss DG, Gross GW: Substance identification by quantitative characterization of oscillatory activity in murine spinal cord networks on microelectrode arrays. Eur J Neurosci 2004;19:2815-2825.
24. Cobbold PH, Rink TJ: Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem J 1987;248:313-323.
25. Williams C: cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov 2004;3:125-135.
26. Frang H, Mukkala V-M, Syysto R, Ollikka P, Hurskainen P, Scheinin M, Hemmilä I: Nonradioactive GTP binding assay to monitor activation of G protein-coupled receptors. Assay Drug Dev Technol 2003;1:275-280.
27. Hodder P, Mull R, Cassaday J, Berry K, Strulovici B: Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader. J Biomol Screen 2004;9:417-426.
28. Le Poul E, Hisada S, Miziguchi Y, Dupriez VJ, Burgeon E, Detheux M: Adaptation of aequorin functional assay to high throughput screening. J Biomol Screen 2002;7:57-65.
29. Roda A, Pasini P, Mirasoli M, Michelini E, Massimo G: Biotechnological applications of bioluminescence and chemiluminescence. Trends Biotechnol 2004;22:295-303.
30. 2+ and membrane potential in lymphocytes. Nature 1982;295:68-71.
31. 2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 1985;6:145-157.
32. Zhang Y, Kowal D, Kramer A, Dunlop J: Evaluation of FLIPR Calcium 3 assay kit - a new no-wash fluorescence calcium indicator reagent. J Biomol Screen 2003;8:571-577.
33. 2+-indicator dyes. J Biomol Screen 2003;8:571-577.
34. Chambers C, Smith F, Williams C, Marcos S, Liu ZH, Hayter P, et al.: Measuring intracellular calcium fluxes in high throughput mode. Comb Chem High Throughput Screen 2003;6:355-362.
35. 2+] using the Fluorometric Imaging Plate Reader (FLIPR). Methods Mol Biol 1999;114:125-133.
36. Schroeder KS, Brad DN: FLIPR: a new instrument for accurate, high throughput optical screening. J Biomol Screen 1996;1:75-80.
37. Xin H, Wang Y, Todd MJ, Qi J, Minor LK: Evaluation of no-wash calcium assay kits: enabling tools for calcium mobilization. J Biomol Screen 2007;12:705-714.
38. 2+-activated photoprotein, Photina®, and its application to high-throughput screening. J Biomol Screen 2007;12:694.
39. Comley J: Assay interference, a limiting factor in HTS? Drug Discov World 2003;4:91-98.
40. Dupriez V, Maes K, Le Poul E, Burgeon E, Detheux M: Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. Receptors Channels 2002;8:319-330.
41. Belogurova NV, Kudryasheva NS, Alieva RR, Sizykh AG: Spectral components of bioluminescence of aequorin and obelin. J Photochem Photobiol B 2008;92:117-122.
42. Fan F, Wood K: Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 2007;5:127-136.
43. Ungrin MD, Singh L, Stocco R, Sas D, Abramovitz M: An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. Anal Biochem 1999;272:34-42.
44. Weissman A, Keefer J, Miagkov A, Sathyamoorthy M, Perschke S, Wang FL: Cell-based screening assays. In: Comprehensive Medicinal Chemistry II, Vol. 3 (Taylor JB, Triggle DJ, eds.), pp. 617-646. Elsevier Ltd., Oxford, UK, 2006.
45. Prendergast F: Bioluminescence illuminated. Nature 2000;405:291-293.
46. 2+-regulated photoproteins: structural insight into the bioluminescence mechanism. Accounts Chem Res 2005;37:405-415.
47. Rowe L, Rothert A, Logue C, Ensor CM, Deo SK, Daunert S: Spectral tuning of photoproteins by partnering site-directed mutagenesis strategies with the incorporation of chromophore analogs. Protein Eng Des Sel 2008;21:73-81.
48. 2+ responses. Science 1998;280:1763-1766.
49. nd ed. (Tepikin A, ed.), pp. 59-75. Oxford University Press, Oxford, UK, 2001.
50. 2+ measurements in mitochondria. In: Measuring Calcium and Calmodulin Inside and Outside Cells (Petersen O, ed.), pp. 187-212. Springer-Verlag, Berlin, 2001.
51. 2+ revealed by specifically targeted recombinant aequorin. Nature 1992;358:325-327.
52. Filippin L, Magalhaes P, Di Benedetto G, Colella M, Pozzan T: Stable interactions between mitochondria and endoplasmic reticulum allow rapid accumulation of calcium in a subpopulation of mitochondria. J Biol Chem 2003;278:39224-39234.
53. Basset O, Boittin F, Dorchies O, Chatton J, van Breemen C, Ruegg U: Involvement of inositol 1,4,5-trisphosphate in nicotinic calcium responses in dystrophic myotubes assessed by near-plasma membrane calcium measurement. J Biol Chem 2004;279:47092-47100.
54. 2+ pump isoforms in intact cells. J Biol Chem 2003;278:24500-24508.
55. 2+ concentration in the endoplasmic reticulum of intact cells. EMBO J 1995;14:5467-5475.
56. Villalobos C, Nadal A, Núñez L, Quesada I, Chamero P, Alonso MT, et al.: Bioluminescence imaging of nuclear calcium oscillations in intact pancreatic islets of Langerhans from the mouse. Cell Calcium 2005;38:131-139.
57. Badminton MN, Kendall JM, Rembold CM, Campbell AK: Current evidence suggests independent regulation of nuclear calcium. Cell Calcium 1998;23:79-86.
58. 2+ concentration measured with specifically targeted recombinant aequorin. EMBO J 1993;12:4813-4819.
59. 2+ store in neuroendocrine cells with a vesicle associated membrane protein aequorin chimaera. J Cell Biol 2001;155:41-51.
60. 2+] changes at the secretory vesicle surface with a recombinant targeted cameleon. Curr Biol 1999;9:918.
61. 2+-sensitive adenylyl cyclase/aequorin chimera. J Biol Chem 1997;272:18093-18097.
62. Watson C, Chen G, Irving P, Way J, Chen W, Kenakin T: The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol 2000;58:1230-1238.
63. i alpha3 and Go alpha selectively associate with the cloned somatostatin receptor subtype SSTR2. J Biol Chem 1993;268:10721-10727.
64. Law S, Reisine T: Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins. Mol Pharmacol 1992;42:398-402.
65. Kenakin T: Efficacy as a vector: the relative prevalence and paucity of inverse agonism. Mol Pharmacol 2004;65:2-11.
66. Yang Q, Lanier S: Influence of G protein type on agonist efficacy. Mol Pharmacol 1999;56:651-656.
67. 2+ in cells. In: Bioluminescence and Chemiluminescence, Basic Chemistry and Analytical Applications (deLuca MA, McElroy WD, eds.), pp. 601-607. Academic Press, New York, 1981.
68. 2+ indicator in biological systems. Biochem J 1985;228:745-749.
69. Inouye S: Cloning, expression, purification and characterization of an isotype of clytin, a calcium-binding photoprotein from the luminous hydromedusa Clytia gregarium. J Biochem (Tokyo) 2008;143:711-717.
70. 2+ based on green fluorescent proteins and calmodulin. Nature 1997;388:882-887.
71. 2+ measurements using improved cameleons. Proc Natl Acad Sci U S A 1999;96:2135-2140.
72. 2+. Proc Natl Acad Sci U S A 1991;98:3197-3202.
73. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A: A variant of yellow fluorescent protein with fast and efficient maturation for cell biological applications. Nat Biotechnol 2002;20:87-90.
74. 2+ concentration with targeted "cameleon" fluorescent proteins. Cell Calcium 2003;34:109-119.
75. 2+ to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions. J Biol Chem 2001;276:29430-29439.
76. Baird GS, Zacharias DA, Tsien RY: Circular permutation and receptor insertion within green fluorescent proteins. Proc Natl Acad Sci U S A 1999;96:11241-11246.
77. Griesbeck O, Baird GS, Campbell RE, Zacharias DA, Tsien RY: Reducing the environmental sensitivity of yellow fluorescent protein: mechanism and applications. J Biol Chem 2001;276:29188-29194.
78. Isshiki M, Ying YS, Fujita T, Anderson RG: A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 2002;277:43389-43398.
79. Kerr R, Lev-Ram V, Baird G, Vincent P, Tsien RY, Schafer WR: Optical imaging of calcium transients in neurons and pharyngeal muscle of C. elegans. Neuron 2000;26:583-594.
80. Suzuki H, Kerr R, Bianchi L, Frøkjaer-Jensen C, Slone D, Xue J, et al.: In vivo imaging of C. elegans mechanosensory neurons demonstrates a specific role for the MEC-4 channel in the process of gentle touch sensation. Neuron 2003;39:1005-1017.
81. Fiala A, Spall T, Diegelmann S, Eisermann B, Sachse S, Devaud JM, et al.: Genetically expressed cameleon in Drosophila melanogaster is used to visualize olfactory information in projection neurons. Curr Biol 2002;12:1877-1884.
82. Martin JR, Rogers KL, Chagneau C, Brûlet P: In vivo bioluminescence imaging of Ca signalling in the brain of Drosophila. PLoS ONE 2007;2:e275.
83. Higashijima S, Masino MA, Mandel G, Fetcho JR: Imaging neuronal activity during zebrafish behavior with a genetically encoded calcium indicator. J Neurophysiol 2003;90:3986-3997.
84. 2+-sensing transgenic mice: postsynaptic signaling in smooth muscle. J Biol Chem 2004;279:21461-21468.
85. 2+ indicator proteins in transgenic mice under TET control. PLoS Biol 2004;2:e163.
86. Rogers KL, Picaud S, Roncali E, Boisgard R, Colasante C, Stinnakre J, et al.: Non-invasive in vivo imaging of calcium signaling in mice. PLoS ONE 2007;2:e974.
87. Gilchrist MA, Cacace A, Harden DG: Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening. J Biomol Screen 2008;13:486-493.
88. Wunder F, Rebmann A, Geerts A, Kalthof B: Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines. Mol Pharmacol 2008;73:1235-1243.